These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients. Menitove JE, Duquesnoy RJ. Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758 [Abstract] [Full Text] [Related]
6. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions. Sandler SG. Haematologia (Budap); 1998 Feb; 29(1):1-11. PubMed ID: 9704252 [Abstract] [Full Text] [Related]
7. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness]. Basire A, Picard C. Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423 [Abstract] [Full Text] [Related]
8. The alloimmunized patient: effective transfusion support and newer experimental approaches. Pamphilon DH. Blood Coagul Fibrinolysis; 1992 Oct; 3(5):651-4. PubMed ID: 1450334 [Abstract] [Full Text] [Related]
9. Strategies for managing refractoriness to platelet transfusions. Dan ME, Schiffer CA. Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147 [Abstract] [Full Text] [Related]
10. A mini-review on platelet refractoriness. Rebulla P. Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579 [Abstract] [Full Text] [Related]
11. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA. McVey M, Cserti-Gazdewich CM. Transfus Med; 2010 Oct; 20(5):346-53. PubMed ID: 20492602 [Abstract] [Full Text] [Related]
12. Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases. Kaibori M, Nagahama T, Yokoigawa N, Yanagida H, Nakamoto H, Kitade H, Satoi S, Onishi S, Kwon AH, Kamiyama Y. Hepatogastroenterology; 2003 Oct; 50(51):832-6. PubMed ID: 12828097 [Abstract] [Full Text] [Related]